Affimed NV Valuation
| AFMDDelisted Stock | USD 0.18 0.04 18.18% |
Affimed NV seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Affimed NV from analyzing the firm fundamentals such as return on equity of -1.49, and Operating Margin of (87.09) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Affimed NV's price fluctuation is very steady at this time. Calculation of the real value of Affimed NV is based on 3 months time horizon. Increasing Affimed NV's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Affimed stock is determined by what a typical buyer is willing to pay for full or partial control of Affimed NV. Since Affimed NV is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Affimed Stock. However, Affimed NV's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.18 | Real 0.17 | Hype 0.18 |
The real value of Affimed Stock, also known as its intrinsic value, is the underlying worth of Affimed NV Company, which is reflected in its stock price. It is based on Affimed NV's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Affimed NV's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Affimed NV helps investors to forecast how Affimed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Affimed NV more accurately as focusing exclusively on Affimed NV's fundamentals will not take into account other important factors: About Affimed NV Valuation
The delisted stock valuation mechanism determines Affimed NV's current worth on a weekly basis. Our valuation model uses a comparative analysis of Affimed NV. We calculate exposure to Affimed NV's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Affimed NV's related companies.Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Affimed N.V. was founded in 2000 and is headquartered in Heidelberg, Germany. Affimed NV operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 197 people.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in Affimed Stock
If you are still planning to invest in Affimed NV check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Affimed NV's history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |